Bor‐Shyang Sheu

Screening and eradication of <i>Helicobacter pylori</i> for gastric cancer prevention: the Taipei global consensus

Jyh‐Ming Liou, Peter Malfertheiner, Yi‐Chia Lee et al. · Gut · 2020 · 470 citations · Full text

Medicine, Oncology, Preventive Medicine +15

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Yu-Jen Fang, Chieh‐Chang Chen et al. · The Lancet · 2016 · 202 citations

Medicine, Pharmacology, Pharmacotherapy +7

Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus

Kwong Ming Fock, Nicholas J. Talley, Khean‐Lee Goh et al. · Gut · 2016 · 199 citations · Full text

Medicine, Clinical Sciences, Clinical Epidemiology +13

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

Shutian Zhang, Ning Dai, Guijun Fei et al. · Gut · 2019 · 149 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Resistance to metronidazole, clarithromycin and levofloxacin of <i>Helicobacter pylori</i> before and after clarithromycin‐based therapy in Taiwan

Wei‐Lun Chang, Bor‐Shyang Sheu, Hsiu‐Chi Cheng et al. · Journal of Gastroenterology and Hepatology · 2009 · 73 citations

Pharmacy, Microbiology, Pharmacology +16